Titan Pharmaceuticals, Inc.
TTNP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,831 | $6,760 | $2,937 | $6,037 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $62 | $1,046 | $36 | $112 |
| Inventory | $0 | $0 | $106 | $293 |
| Other Curr. Assets | $30 | $212 | $524 | $787 |
| Total Curr. Assets | $2,923 | $8,018 | $3,603 | $7,229 |
| Property Plant & Equip (Net) | $0 | $68 | $407 | $717 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $48 | $48 |
| Total NC Assets | $0 | $68 | $455 | $765 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,923 | $8,086 | $4,058 | $7,994 |
| Liabilities | – | – | – | – |
| Payables | $202 | $348 | $695 | $795 |
| Short-Term Debt | $0 | $565 | $122 | $224 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $12 | $196 | $295 |
| Other Curr. Liab. | $281 | $519 | $1,617 | $1,355 |
| Total Curr. Liab. | $483 | $1,444 | $2,630 | $2,669 |
| LT Debt | $0 | $0 | $65 | $187 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $65 | $187 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $65 | $187 | $299 |
| Total Liabilities | $483 | $1,444 | $2,695 | $2,856 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $10 |
| Retained Earnings | -$396,536 | -$391,830 | -$386,261 | -$376,055 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $398,974 | $398,470 | $387,623 | $381,183 |
| Total Equity | $2,440 | $6,642 | $1,363 | $5,138 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,923 | $8,086 | $4,058 | $7,994 |
| Net Debt | -$2,831 | -$6,195 | -$2,750 | -$5,626 |